My NCBISign In

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 2014

    1.

    Toll-like receptor 4-dependent upregulation of cytokines in a transgenic mouse model of Alzheimer's disease.

    Jin JJ, Kim HD, Maxwell JA, Li L, Fukuchi K.

    J Neuroinflammation. 2008 May 29;5:23.PMID: 18510752 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Role of toll-like receptor signalling in Abeta uptake and clearance.

    Tahara K, Kim HD, Jin JJ, Maxwell JA, Li L, Fukuchi K.

    Brain. 2006 Nov;129(Pt 11):3006-19. Epub 2006 Sep 19.PMID: 16984903 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Overexpression of human S100B exacerbates cerebral amyloidosis and gliosis in the Tg2576 mouse model of Alzheimer's disease.

    Mori T, Koyama N, Arendash GW, Horikoshi-Sakuraba Y, Tan J, Town T.

    Glia. 2010 Feb;58(3):300-14.PMID: 19705461 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Interferon-gamma and tumor necrosis factor-alpha regulate amyloid-beta plaque deposition and beta-secretase expression in Swedish mutant APP transgenic mice.

    Yamamoto M, Kiyota T, Horiba M, Buescher JL, Walsh SM, Gendelman HE, Ikezu T.

    Am J Pathol. 2007 Feb;170(2):680-92.PMID: 17255335 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Differential regulation of toll-like receptor mRNAs in amyloid plaque-associated brain tissue of aged APP23 transgenic mice.

    Frank S, Copanaki E, Burbach GJ, Müller UC, Deller T.

    Neurosci Lett. 2009 Mar 27;453(1):41-4. Epub 2009 Feb 4.PMID: 19429012 [PubMed - indexed for MEDLINE]Related articles

    7.

    Neutralization of granulocyte macrophage colony-stimulating factor decreases amyloid beta 1-42 and suppresses microglial activity in a transgenic mouse model of Alzheimer's disease.

    Manczak M, Mao P, Nakamura K, Bebbington C, Park B, Reddy PH.

    Hum Mol Genet. 2009 Oct 15;18(20):3876-93. Epub 2009 Jul 19.PMID: 19617638 [PubMed - indexed for MEDLINE]Related articles

    9.

    Inflammatory responses to amyloidosis in a transgenic mouse model of Alzheimer's disease.

    Matsuoka Y, Picciano M, Malester B, LaFrancois J, Zehr C, Daeschner JM, Olschowka JA, Fonseca MI, O'Banion MK, Tenner AJ, Lemere CA, Duff K.

    Am J Pathol. 2001 Apr;158(4):1345-54.PMID: 11290552 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    MAPK-activated protein kinase 2 deficiency in microglia inhibits pro-inflammatory mediator release and resultant neurotoxicity. Relevance to neuroinflammation in a transgenic mouse model of Alzheimer disease.

    Culbert AA, Skaper SD, Howlett DR, Evans NA, Facci L, Soden PE, Seymour ZM, Guillot F, Gaestel M, Richardson JC.

    J Biol Chem. 2006 Aug 18;281(33):23658-67. Epub 2006 Jun 14.PMID: 16774924 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Toll-like receptor 2 acts as a natural innate immune receptor to clear amyloid beta 1-42 and delay the cognitive decline in a mouse model of Alzheimer's disease.

    Richard KL, Filali M, Préfontaine P, Rivest S.

    J Neurosci. 2008 May 28;28(22):5784-93.PMID: 18509040 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Induction of cytokines in glial cells surrounding cortical beta-amyloid plaques in transgenic Tg2576 mice with Alzheimer pathology.

    Mehlhorn G, Hollborn M, Schliebs R.

    Int J Dev Neurosci. 2000 Jul-Aug;18(4-5):423-31.PMID: 10817926 [PubMed - indexed for MEDLINE]Related articles

    13.

    Amyloid deposition and inflammation in APPswe/PS1dE9 mouse model of Alzheimer's disease.

    Ruan L, Kang Z, Pei G, Le Y.

    Curr Alzheimer Res. 2009 Dec;6(6):531-40.PMID: 19747158 [PubMed - indexed for MEDLINE]Related articles

    14.

    Fibrillar amyloid-beta peptides activate microglia via TLR2: implications for Alzheimer's disease.

    Jana M, Palencia CA, Pahan K.

    J Immunol. 2008 Nov 15;181(10):7254-62.PMID: 18981147 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    CD45 opposes beta-amyloid peptide-induced microglial activation via inhibition of p44/42 mitogen-activated protein kinase.

    Tan J, Town T, Mori T, Wu Y, Saxe M, Crawford F, Mullan M.

    J Neurosci. 2000 Oct 15;20(20):7587-94.PMID: 11027218 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Up-regulation of the inflammatory cytokines IFN-gamma and IL-12 and down-regulation of IL-4 in cerebral cortex regions of APP(SWE) transgenic mice.

    Abbas N, Bednar I, Mix E, Marie S, Paterson D, Ljungberg A, Morris C, Winblad B, Nordberg A, Zhu J.

    J Neuroimmunol. 2002 May;126(1-2):50-7.PMID: 12020956 [PubMed - indexed for MEDLINE]Related articles

    18.

    Possible role of scavenger receptor SRCL in the clearance of amyloid-beta in Alzheimer's disease.

    Nakamura K, Ohya W, Funakoshi H, Sakaguchi G, Kato A, Takeda M, Kudo T, Nakamura T.

    J Neurosci Res. 2006 Sep;84(4):874-90.PMID: 16868960 [PubMed - indexed for MEDLINE]Related articles

    19.

    Microglia initiate central nervous system innate and adaptive immune responses through multiple TLRs.

    Olson JK, Miller SD.

    J Immunol. 2004 Sep 15;173(6):3916-24.PMID: 15356140 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Microglial dysfunction and defective beta-amyloid clearance pathways in aging Alzheimer's disease mice.

    Hickman SE, Allison EK, El Khoury J.

    J Neurosci. 2008 Aug 13;28(33):8354-60.PMID: 18701698 [PubMed - indexed for MEDLINE]Related articlesFree article

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Find related data

    Write to the Help Desk